Pyridorin in Diabetic Nephropathy
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
137 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Csg Investigational Site (#205)
Camperdown, New South Wales, Australia
- Csg Investigational Site (#201)
Gosford, New South Wales, Australia
- Csg Investigational Site (#206)
Liverpool, New South Wales, Australia
- Csg Investigational Site (#208)
St Leonards, New South Wales, Australia
- Csg Investigative Site (#204)
Adelaide, South Australia, Australia
- Csg Investigational Site (#207)
Footscray, Victoria, Australia
- Csg Investigational Site (#200)
Reservoir, Victoria, Australia
- Csg Investigational Site (#202)
Richmond, Victoria, Australia
- Csg Investigational Site (#209)
Parkville, Australia
- Csg Investigational Site (#757)
Plovdiv, Bulgaria
- Csg Investigational Site (# 750)
Sofia, Bulgaria
- Csg Investigational Site (# 755)
Sofia, Bulgaria
- Csg Investigational Site (# 756)
Sofia, Bulgaria
- Csg Investigational Site (#751)
Sofia, Bulgaria
- Csg Investigational Site (#752)
Sofia, Bulgaria
- Csg Investigational Site (#753)
Sofia, Bulgaria
- Csg Investigational Site (#754)
Stara Zagora, Bulgaria
- Csg Investigational Site (#801)
Grenoble, Cedex, France
- Csg Investigational Site (#802)
Paris, Cedex, France
- Csg Investigational Site (#800)
Boulogne-sur-Mer, France
- Csg Investigational Site (#803)
Colmar, France
- Csg Investigational Site (#806)
Montpellier, France
- Csg Investigational Site (#804)
Rhone, France
- Csg Investigational Site (#805)
Valenciennes, France
- Csg Investigational Site (#709)
Aschaffenburg, Germany
- Csg Investigative Site (#702)
Berlin, Germany
- Csg Investigational Site (#706)
Elsterwerda, Germany
- Csg Investigational Site (#703)
Heidelberg, Germany
- Csg Investigational Site (#707)
Herzberg, Germany
- Csg Investigational Site (#701)
Hoyerswerda, Germany
- Csg Investigational Site (#708)
Mainz, Germany
- Csg Investigational Site (#700)
München, Germany
- Csg Investigational Site (#400)
Hong Kong, Hong Kong
- Csg Investigational Site (#402)
Kwai Chung, Hong Kong
- Csg Investigational Site (#401)
Shatin, Hong Kong
- Csg Investigational Site (#501)
Balatonfüred, Hungary
- Csg Investigational Site (#505)
Budapest, Hungary
- Csg Investigational Site (#509)
Budapest, Hungary
- Csg Investigational Site (#513)
Budapest, Hungary
- Csg Investigational Site (#507)
Debrecen, Hungary
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2014
- Primary completion
- 31 Dec 2017
- Completion
- 31 Mar 2018
- Last update posted
- 9 Mar 2016
- Registered enrollment
- 328
- Registry id
- NCT02156843
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.